Volume 116, Issue 2, Pages 286-293 (February 1999) Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1 Guillaume Cadiot, Albert Vuagnat, Isabelle Doukhan, Arnaud Murat, Guillaume Bonnaud, Brigitte Delemer, Gérard Thiéfin, Albert Beckers, Michel Veyrac, Charles Proye, Philippe Ruszniewski, Michel Mignon Gastroenterology Volume 116, Issue 2, Pages 286-293 (February 1999) DOI: 10.1016/S0016-5085(99)70124-1 Copyright © 1999 American Gastroenterological Association Terms and Conditions
Fig. 1 Probability of developing LM (Kaplan–Meier) for 77 patients with ZES and MEN-1. Gastroenterology 1999 116, 286-293DOI: (10.1016/S0016-5085(99)70124-1) Copyright © 1999 American Gastroenterological Association Terms and Conditions
Fig. 2 Probability of developing LM (Kaplan–Meier). Patients were divided into 3 groups: no pancreatic tumor (○), pancreatic tumors <3 cm (2), and pancreatic tumors ≥3 cm (●), which were compared with the log rank test. One of the 4 patients with pancreatic tumors of unknown size (not represented in the figure) also developed LM. Gastroenterology 1999 116, 286-293DOI: (10.1016/S0016-5085(99)70124-1) Copyright © 1999 American Gastroenterological Association Terms and Conditions
Fig. 3 Survival probability (Kaplan–Meier) according to the development of metachronous LM during follow-up (log rank test). Gastroenterology 1999 116, 286-293DOI: (10.1016/S0016-5085(99)70124-1) Copyright © 1999 American Gastroenterological Association Terms and Conditions
Fig. 4 Survival probability (Kaplan–Meier) according to ZES diagnosis before 1980 (●) or after 1980 (○) (log rank test). Gastroenterology 1999 116, 286-293DOI: (10.1016/S0016-5085(99)70124-1) Copyright © 1999 American Gastroenterological Association Terms and Conditions